Literature DB >> 25762772

A statistical approach for determination of disk diffusion-based cutoff values for systematic characterization of wild-type and non-wild-type bacterial populations in antimicrobial susceptibility testing.

Giorgia Valsesia1, Malgorzata Roos2, Erik C Böttger1, Michael Hombach3.   

Abstract

In this study, we introduce a new approach for determination of epidemiologic cutoffs (ECOFFs) and resistant-population cutoffs (RCOFFs) based on receiver operating characteristic (ROC) curves. As an example, the method was applied for determination of ECOFFs for seven different beta-lactam antibiotics and wild-type populations of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae. In addition, RCOFFs were determined for bacterial populations with defined resistance mechanisms ("resistotypes"), i.e., extended-spectrum beta-lactamase (ESBL)-positive E. coli, ESBL-positive K. pneumoniae, and ESBL-positive E. cloacae; AmpC cephalosporinase-positive E. coli and AmpC-positive K. pneumoniae; and broad-spectrum beta-lactamase (BSBL)-positive E. coli. RCOFFs and ECOFFs are instrumental for a systematic characterization of associations between resistotypes and wild-type populations.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25762772      PMCID: PMC4432064          DOI: 10.1128/JCM.03506-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  48 in total

Review 1.  Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests.

Authors:  M Greiner; D Pfeiffer; R D Smith
Journal:  Prev Vet Med       Date:  2000-05-30       Impact factor: 2.670

2.  Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae.

Authors:  Silke Polsfuss; Guido V Bloemberg; Jacqueline Giger; Vera Meyer; Erik C Böttger; Michael Hombach
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

Review 3.  Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?

Authors:  David M Livermore; Jenny M Andrews; Peter M Hawkey; Pak-Leung Ho; Yoram Keness; Yohei Doi; David Paterson; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2012-03-29       Impact factor: 5.790

4.  Normalized resistance interpretation as a tool for establishing epidemiological MIC susceptibility breakpoints.

Authors:  Göran Kronvall
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

Review 5.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.

Authors:  Johann D D Pitout; Kevin B Laupland
Journal:  Lancet Infect Dis       Date:  2008-03       Impact factor: 25.071

Review 6.  Setting interpretive breakpoints for antimicrobial susceptibility testing using disk diffusion.

Authors:  Göran Kronvall; Christian G Giske; Gunnar Kahlmeter
Journal:  Int J Antimicrob Agents       Date:  2011-06-02       Impact factor: 5.283

7.  β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.

Authors:  Jesús Rodríguez-Baño; María Dolores Navarro; Pilar Retamar; Encarnación Picón; Álvaro Pascual
Journal:  Clin Infect Dis       Date:  2011-11-04       Impact factor: 9.079

8.  Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.

Authors:  Patricia J Simner; George G Zhanel; Johann Pitout; Franil Tailor; Melissa McCracken; Michael R Mulvey; Philippe R S Lagacé-Wiens; Heather J Adam; Daryl J Hoban
Journal:  Diagn Microbiol Infect Dis       Date:  2011-03       Impact factor: 2.803

9.  Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.

Authors:  Silke Polsfuss; Guido V Bloemberg; Jacqueline Giger; Vera Meyer; Michael Hombach
Journal:  J Antimicrob Chemother       Date:  2011-10-03       Impact factor: 5.790

Review 10.  Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms.

Authors:  Katherine Yang; B Joseph Guglielmo
Journal:  Ann Pharmacother       Date:  2007-07-31       Impact factor: 3.154

View more
  5 in total

1.  The Resistant-Population Cutoff (RCOFF): a New Concept for Improved Characterization of Antimicrobial Susceptibility Patterns of Non-Wild-Type Bacterial Populations.

Authors:  Giorgia Valsesia; Michael Hombach; Florian P Maurer; Patrice Courvalin; Malgorzata Roos; Erik C Böttger
Journal:  J Clin Microbiol       Date:  2015-03-11       Impact factor: 5.948

2.  Determination of MIC distribution and epidemiological cutoff values for bedaquiline and delamanid in Mycobacterium tuberculosis using the MGIT 960 system equipped with TB eXiST.

Authors:  Peter M Keller; Rico Hömke; Claudia Ritter; Giorgia Valsesia; Guido V Bloemberg; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2015-05-04       Impact factor: 5.191

3.  Genomic, morphological, and biochemical analyses of a multi-metal resistant but multi-drug susceptible strain of Bordetella petrii from hospital soil.

Authors:  Urmi Halder; Raju Biswas; Ashutosh Kabiraj; Rajendar Deora; Moitri Let; Rajendra Kr Roy; Annapurna Chitikineni; Krishnendu Majhi; Shrabana Sarkar; Bhramar Dutta; Anubhab Laha; Arunava Datta; Dibyendu Khan; Rajeev K Varshney; Dipnarayan Saha; Saswati Chattopadhyay; Rajib Bandopadhyay
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

4.  Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin.

Authors:  Xia Yu; Guirong Wang; Suting Chen; Guomei Wei; Yuanyuan Shang; Lingling Dong; Thomas Schön; Danesh Moradigaravand; Julian Parkhill; Sharon J Peacock; Claudio U Köser; Hairong Huang
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

5.  Antimicrobial Resistance of Clinical and Commensal Escherichia coli Canine Isolates: Profile Characterization and Comparison of Antimicrobial Susceptibility Results According to Different Guidelines.

Authors:  Vera Fernandes; Eva Cunha; Telmo Nunes; Elisabete Silva; Luís Tavares; Luísa Mateus; Manuela Oliveira
Journal:  Vet Sci       Date:  2022-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.